Blog Archives

PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity

VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for Parkinson’s disease diagnostics and treatment.

Quantitative Motor Assessment of Gait and Lower Extremity Bradykinesia Following the Discontinuation of Deep Brain Stimulation

View the poster T. Mera, D. Riley, B. Walter, A. Espay, F. Revilla, J. Giuffrida 3rd World Parkinson Congress. Montreal, Canada, 2013

Quantitative Analysis Of Gait And Balance Response To Deep Brain Stimulation In Parkinson’s Disease

T. Mera, D. Filipkowski, D. Riley, C. Whitney, B. Walter, S. Gunzler, J. Giuffrida Gait & Posture. 2013 May;38(1):109-14

Automated motion sensor quantification of gait and lower extremity bradykinesia

D. Heldman, D. Filipkowski, R. Riley, C. Whitney, B. Walter, S. Gunzler, T. Mera Conf Proc IEEE Eng Med Biol Soc. 2012.

PRESS RELEASE: GLNT Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson’s Disease and Neuroscience Education

VIEW PRESS RELEASE [PDF] April 24, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of Health’s SBIR program. Each project is focused on developing and

Read more ›

PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] March 23, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with Parkinson’s disease (PD). The study, funded by the National Institutes

Read more ›

PRESS RELEASE: Great Lakes NeuroTechnologies’ KinetiSense technology used in Parkinson’s disease gait and balance study

VIEW PRESS RELEASE [PDF] Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology was used in a clinical study to capture and quantify the effect of Deep Brain Stimulation (DBS) on gait and balance impairment in Parkinson’s disease (PD). DBS surgery is typically performed when

Read more ›

Automated Parkinson’s Disease Gait and Balance Assessment for Optimization of Deep Brain Stimulation

T. Mera, D. Filipkowski, Riley R, Walter B, Gunzler S, J. Giuffrida International Congress of Parkinson’s Disease and Movement Disorders, Toronto, CA 2011